EPISODE · Jun 22, 2026 · 15 MIN
晨间信号 (MorningSignalDaily) 2026年6月23日
from 晨间信号MS
今天的重点新闻：第一件：Definium的LSD疗法DT120在III期临床中单次给药就使重度抑郁评分大降，疗效远超安慰剂并持续达12周，但公司警告不同试验间比较可能高估优势，这是抑郁症治疗的革命性疗法的前奏，还是仍要面对监管与临床落地的漫长征途？第二件：辉瑞与信达生物仅用不到五个月就达成涵盖12款药物的105亿美元肿瘤药大单，双方都希望以一次捆绑合作取代多个独立联盟，延续了去年葛兰素史克与恒瑞的同类大手笔，这究竟是跨国药企对中国创新药的高效整合，还是多资产捆绑模式下的又一次快速复制？
Embed this episode
Ready to play
晨间信号 (MorningSignalDaily) 2026年6月23日
0:00
15:07
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 晨间信号MS?
This episode is 15 minutes long.
When was this 晨间信号MS episode published?
This episode was published on June 22, 2026.
Can I download this 晨间信号MS episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!